Source:http://linkedlifedata.com/resource/pubmed/id/10730184
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-4-24
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0750-7658
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
Fi45-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10730184-Anesthesia, General,
pubmed-meshheading:10730184-Anesthesiology,
pubmed-meshheading:10730184-Dantrolene,
pubmed-meshheading:10730184-France,
pubmed-meshheading:10730184-Humans,
pubmed-meshheading:10730184-Malignant Hyperthermia,
pubmed-meshheading:10730184-Muscle Relaxants, Central
|
pubmed:year |
2000
|
pubmed:articleTitle |
[Letter DGS/DH dated November 18, 1999 on the treatment of paranesthetic malignant hyperthermia (MH)].
|
pubmed:publicationType |
Letter
|